Press release
Drug Eluting Stents Market is expected to grow at a CAGR of 6.6 % from 2023-2030 : Cognitive Market Research
Drug Eluting Stents Market is expected to grow at a CAGR of 6.6 % from 2023-2030 : Cognitive Market Research
Drug-eluting stent is a peripheral or coronary stent placed into narrowed, diseased peripheral, or coronary arteries that gradually release a drug to block cell proliferation. Drug-eluting stents are covered with medication, which is released to stop the growth of scar tissues in arterial walls. The eluted drug supports arteries to remain smooth and exposed, which confirms suitable blood flow and decreases the probability of restenosis. DES is observed as the gold standard for the treatment of coronary heart disease, as it provides various profits such as enhanced vessel healing, minimally invasive nature, and reduced need for prolonged dual antiplatelet therapy.
Summary:
• The global Drug Eluting Stents market is estimated to be valued at US$ 2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).
• Besides, the report covers a complete manufacturer's analysis. Additionally, it provides sales channels, analysis findings, and results. The report covers a holistic analysis of external and internal factors affecting the growth of the market. It spots some new entrants within the market. The study thus, suggests a brand-new proposition to embellish the drug-eluting stents market and nurture business as it explains the current global market as well as the future market.
To know more The Drug Eluting Stents market statistics click here:
https://www.cognitivemarketresearch.com/drug-eluting-stents-market-report
Market Dynamics
Growing unhealthy food habits, lack of exercise, and sedentary lifestyles increase the prevalence of atherosclerosis which boosts the demand for the global market. In addition, the rising geriatric population drives the growth of the drug-eluting stents market. Furthermore, the increasing prevalence of several cardiovascular diseases such as abnormal heart rhythms, heart attacks, and many others provides opportunities to the market players. However, strict government regulations for product approval may hamper the growth of the global market.
Market Segmentation:
By Drug
• Sirolimus
• Paclitaxel
• Zotarolimus
• Everolimus
• Biolimus
• Others
By drug type, the market is segmented into sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, and others. The Sirolimus segment is anticipated to drive the demand for the growth of the global market. This is attributed to the high preference among end users.
By Coating Type
• Polymer-based Coatings
• Polymer-free Coatings
By coating type the market is segmented into polymer-based coating, and polymer-free coatings. The polymer-free coating segment has the largest revenue share for the growth of the global market. This is attributed to the quicker drug eluting rate and higher drug loading capacity of nanoporous surfaces.
By Application:
• Coronary Artery Diseases
• Peripheral Artery Diseases
The coronary artery disease segment is anticipated to dominate the global market, due to the rise in the prevalence of coronary artery disease, and the increase in the adoption of drug-eluting stents.
By End User:
• Cardiology Centers
• Ambulatory Surgery Centers (ASCs)
• Hospitals
The market is segmented into Hospitals, Ambulatory Surgical Centers, Cardiology Centers, and Others. Hospitals are accounted for the major revenue share for the growth of the global market. Rising healthcare expenditure and the development of new hospitals in emerging countries drive global market growth.
Competitive Analysis for Drug Eluting Stents market:
Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, Terumo Medical
Get free sample pages of latest published Drug Eluting Stents market Report:
https://www.cognitivemarketresearch.com/drug-eluting-stents-market-report#request_sample
Regional Analysis
North America dominates the drug-eluting stents market with the highest revenue share. This is attributed to the increasing geriatric population, the development of the R&D sector, and the rise in healthcare reforms, which are expected to drive the demand for the growth of the global market. Furthermore, Asia Pacific is anticipated to register the growth of the global market with the highest growth rate. increase in the prevalence of coronary artery disease and peripheral artery disease is anticipated to drive the demand for the global market in the country in the region.
News:
In May 2022, Medtronic plc received United States Food and Drug Administration (FDA) approval for the Onyx Frontier drug-eluting stent (DES). Onyx Frontier DES, the newest member of the Resolute DES family, has the same best-in-class stent platform as Resolute OnyxTM DES and includes a new administration mechanism designed to improve acute performance in the most problematic individuals.
Browse Here For Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global Drug Eluting Stents Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Drug Eluting Stents Market Segmentation
1.5.1 Drug Eluting Stents Market Regional Fragmentation
1.5.1 Drug Eluting Stents Market Players
• 1.6 Report Duration
Chapter 2 Research MethodologyReview Complete Research Methodology
Chapter 3 Executive Summary of Drug Eluting Stents Market
• 3.1 Global Drug Eluting Stents Market Size 2018 - 2030, (USD Million)
• 3.2 Global Drug Eluting Stents Market Statistics 2022: Snapshot
Chapter 4 Global Drug Eluting Stents Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global Drug Eluting Stents Market by Type Segmentation Analysis (2018-2030)
Chapter 9 Global Drug Eluting Stents Market by Application Segmentation Analysis (2018-2030)
Chapter 10 Global Drug Eluting Stents Market by Coating Type Segmentation Analysis (2018-2030)
Chapter 11 Global Drug Eluting Stents Market by End User Segmentation Analysis (2018-2030)
Chapter 12 Global Drug Eluting Stents Market Regional Analysis
Chapter 13 North America Drug Eluting Stents Market Outlook (2018 - 2030)
Chapter 14 Europe Drug Eluting Stents Market Outlook (2018 - 2030)
Chapter 15 Asia Pacific Drug Eluting Stents Market Outlook (2018 - 2030)
Chapter 16 Latin America Drug Eluting Stents Market Outlook (2018 - 2030)
Chapter 17 Middle East and Africa Drug Eluting Stents Market Outlook (2018 - 2030)
Chapter 18 Research Findings
To know more Drug Eluting Stents Market TOC click here:
https://www.cognitivemarketresearch.com/drug-eluting-stents-market-report#table_of_contents
Related Reports
Coronary Stent Market
https://www.cognitivemarketresearch.com/coronary-stent-market-report
China Drug Eluting Stent Market:
https://www.cognitivemarketresearch.com/drug-eluting-stents-market-report
Durable Drug Eluting Stents Market:
https://www.cognitivemarketresearch.com/durable-drug-eluting-stents-market-report
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us
About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Eluting Stents Market is expected to grow at a CAGR of 6.6 % from 2023-2030 : Cognitive Market Research here
News-ID: 2961446 • Views: …
More Releases from Cognitive Market Research
Ultra Fine Copper Powder Market is estimated to grow at a CAGR of 7.1% during th …
Market Overview:
- The term "ultra-fine copper powder" refers to a finely divided type of copper that is distinguished by its exceedingly small particle size and large surface area. It is made using a variety of processes, such as mechanical grinding, electrolysis, and chemical precipitation. Ultra-fine copper powder typically has particles between a few nanometres and a few micrometers in size.
Summary:
- As per Cognitive Market Research, Global Ultra-Fine Copper…
Premium Branding and Status Symbol boosts the Global Metal Card Market: Cognitiv …
Market Overview:
- A metal card typically refers to a credit or debit card that is made from metal materials instead of traditional plastic. These cards are often associated with premium or high-end credit card offerings and are designed to provide a more luxurious and prestigious feel. Metal cards are usually made from materials such as stainless steel, titanium, or other alloys, which gives them a solid and durable construction.…
Slot Machines Market is projected to grow at a CAGR of 12.9% within the forecast …
Market Overview:
A slot machine is operated by inserting coins into a slot and by pulling down on a long handle. It features a set of spinning reels with various symbols on them. Players or individuals insert coins or tokens into the machine and then pull a lever or press a button to activate the reels. The earliest slot machine technology was created with mechanical reels powered by random number generators.…
Mechanical Seals Market is estimated to grow at a CAGR of 4.8% within the foreca …
Market Overview:
A mechanical seal is only a way to keep fluid inside a vessel usually pumps, mixers, etc. when a rotating shaft passes through a stationary housing or, on rare occasions, when the housing rotates around the shaft. Mechanical seals are devices used to prevent leakage between two components or systems that are connected by a rotating shaft. They are commonly used in pumps, compressors, mixers, and other equipment that…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
